tradingkey.logo
tradingkey.logo
Search

Bayer: Gadoquatrane New Drug Application Accepted For Review By U.S. FDA

ReutersAug 27, 2025 6:31 AM
facebooktwitterlinkedin

- Bayer AG BAYGn.DE:

  • GADOQUATRANE NEW DRUG APPLICATION ACCEPTED FOR REVIEW BY U.S. FDA

  • FURTHER REGULATORY APPLICATIONS TO HEALTH AUTHORITIES WORLDWIDE ARE PLANNED FOR COMING MONTHS

Source text: [ID:]

Further company coverage: BAYGn.DE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI